Hirakata, Japan

Takashi Imagawa

This inventor holds 4 USPTO granted patents. Top assignee: The Green Cross Corporation. Active years: 1981-1996.


% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Sakai, JP (1981)
  • Hyogo, JP (1987)
  • Hirakata, JP (1995)
  • Osaka, JP (1996)

Company Filing History:


Years Active: 1981-1996

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Takashi Imagawa: Innovator in Chelating Agents

Introduction

Takashi Imagawa is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of chemistry, particularly in the development of chelating agents and complex compounds. With a total of 4 patents to his name, his work has implications in medical diagnostics.

Latest Patents

Imagawa's latest patents focus on a chelating agent and a complex compound that includes a metallic atom. The compound is characterized by a specific formula where m is an integer from 1 to 3, and R1 and R2 can be hydrogen or lower alkyl groups. Additionally, R3, R4, R5, and R6 can be hydroxyl or other specified groups. This innovative compound is particularly useful as a contrast medium for image diagnosis, showcasing superior characteristics in medical applications.

Career Highlights

Throughout his career, Takashi Imagawa has been associated with The Green Cross Corporation. His work has been instrumental in advancing the understanding and application of chelating agents in various fields, especially in medical imaging.

Collaborations

Imagawa has collaborated with notable coworkers, including Ikuko Miyagi and Fumio Mori. Their combined expertise has contributed to the successful development of innovative solutions in their respective fields.

Conclusion

Takashi Imagawa's contributions to the field of chemistry, particularly through his patents on chelating agents, highlight his role as an influential inventor. His work continues to impact medical diagnostics positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…